How should we report these subsequent graft replacements? Are 15300-15301 still appropriate and, if so, do we need a modifier? Or do other codes apply?
Pennsylvania Subscriber
Answer: Allograft placement as described by 15300 (Allograft skin for temporary wound closure, trunk, arms, legs; first 100 sq cm or less, or 1 percent of body area of infants and children) and +15301 (... each additional 100 sq cm, or each additional 1 percent of body area of infants and children, or part thereof ...) is frequently not a -one time and done- procedure. The surgeon must continually replace the graft until the patient's own skin regenerates. In this way, the allograft acts as a temporary closure to reduce the risk of infection.
Because 15300 includes a 90-day global period, follow-up graft procedures almost always occur within this time period.
You are correct to continue to report 15300 and 15301 (as appropriate) for replacement grafts during the global period: No other codes better describe the procedure. As you guess, however, you must also apply a modifier -quot; in this case modifier 58 (Staged or related procedure or service by the same physician during the postoperative period) -quot; to indicate that the graft replacement should not be bundled to the original procedure.
Modifier 58 is appropriate because the graft replacement represents a -staged procedure- that is related to and prospectively planned at the time of the original graft. You can perform the procedure in the office or bedside: You do not have to return the patient to the OR to report modifier 58.
Note: The above advice also applies for all allograft codes 15320-15366.
Caution: You should not report allograft placement codes 15300-15366 if the clinician simply replaces dressings, etc., during the global period. Dressing changes are included in the original procedure and are not separately reimbursable.